DNM1L and Parkinson disease: Taken together, our findings indicate that an inhibitor of ROCK1 activation exerts neuroprotective effects in a PD mouse model by inhibiting Drp1-dependent aberrant mitochondrial fission and apoptosis, suggesting that ROCK1 and Drp1 may be potential therapeutic targets for PD.